United States Department of Agriculture   Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Washington DC United States (1862)

Organization Overview

First Clinical Trial
2001
NCT02219399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Agriculture Research Service, United States Department of Agriculture, Grand Forks Human Nutrition Research Center | Jean Mayer USDA Human Nutrition Research Center on Aging | Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA), Boston | United States Department of Agriculture Foreign Agricultural Service | United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA) | United States Department of Agriculture (USDA) | USDA Agricultural Research Station in Albany, CA | USDA ARS | USDA/ARS | USDA-ARS, Beltsville Human Nutrition Research Center | USDA ARS Western Human Nutrition Research Center | USDA-ARS-Western Human Nutrition Research Center | USDA, ARS, Western Human Nutrition Research Center | USDA, ARS, WHNRC | USDA Beltsville Human Nutrition Research Center | USDA Grand Forks Human Nutrition Research Center | USDA Human Nutrition Research Center on Aging | USDA, Staff Scientist | USDA, Western Human Nutrition Research Center

Active Ingredients

Drugs in Phase 4 Trials (2)

soybean (2 trials)

zinc dichloride (1 trial)

Drugs in Phase 3 Trials (4)

fish oil (Omegavan) (6 trials)

icosapent ethyl (vascepa) (4 trials)

vitamin k (1 trial)

zinc (2 trials)

Drugs in Phase 2 Trials (3)

bifidobacterium animalis (1 trial)

pear (1 trial)

red beetroot (1 trial)

Drugs in Phase 1 Trials (7)

acetylsalicylic acid (aspirin) (1 trial)

cinnamon (1 trial)

inulin (1 trial)

lipopolysaccharide (1 trial)

maltodextrin (2 trials)

ty21a (1 trial)

typhoid vaccine, live oral (Vivotif) (1 trial)

Drugs in Other Trials (50)

alfalfa (1 trial)

alfalfa sprout homogenate (1 trial)

almond (1 trial)

apple (1 trial)

blueberry allergenic extract (4 trials)

broccoli (2 trials)

broccoli sprout (1 trial)

calcium (2 trials)

calcium carbonate (1 trial)

cherry (1 trial)

choline c11 (choline c-11) (1 trial)

citrus limonoid (1 trial)

cocoa powder (1 trial)

corn (2 trials)

cranberry (1 trial)

egg (1 trial)

ergocalciferol (drisdol) (1 trial)

fatty acid (1 trial)

guar gum (1 trial)

hydroxocobalamin (cyanokit) (1 trial)

ibuprofen (motrin) (2 trials)

kale (1 trial)

lycopene (1 trial)

magnesium oxide (1 trial)

mango (1 trial)

medium chain triglyceride (2 trials)

oat (1 trial)

oleacein (1 trial)

oleocanthal (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

omeprazole (prilosec) (1 trial)

pilocarpine (ocusert) (1 trial)

resistant starch (1 trial)

rifaximin (xifaxan) (1 trial)

rutin (1 trial)

selenomethionine se-75 (1 trial)

sodium phytate (1 trial)

soybean oil (Intralipid) (1 trial)

strawberry (1 trial)

sunflower oil (1 trial)

tea (1 trial)

tomato (1 trial)

uv-b treated mushrooms (1 trial)

vitamin a (1 trial)

vitamin c (1 trial)

vitamin d3 (3 trials)

vitamin e (1 trial)

vitis vinifera (3 trials)

wheat (1 trial)

xanthophyll (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Calcinosis (Phase 3)

Cardiovascular Diseases (Phase 3)

Endotoxemia (Phase 1)

Inflammation (Phase 3)

Insulin Resistance (Phase 1)

Metabolic Syndrome (Phase 2)

Osteoporosis (Phase 4)

Overweight (Phase 2)

Polycystic Ovary Syndrome (Phase 1)

Syndrome (Phase 2)

Typhoid Fever (Phase 1)

Vascular Calcification (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 70
  • # of Trial APIs: 66